Patent classifications
C07C237/40
ISOPHTHALAMINDE COMPOUND AND USE THEREOF
This disclosure provides an isophthalamide compound and use thereof, wherein the compound has a structure as shown by general formula I:
##STR00001##
the definition of each substituent in the formula is shown in the specification. The specification also discloses use thereof as an insecticide and an animal parasite control agent.
Diamine, Polymer and Film Produced Using the Same
The present invention relates to a diamine, and a polymer and film produced using the same. Specifically, the diamine may be significantly effectively used as a monomer for producing a polyimide-based film that is colorless and transparent and has improved mechanical strength.
Diamine Compound, Polyimide Precursor and Polyimide Prepared by Using the Same, Composition for Forming Polyimide Film and Polyimide Film Prepared by Using the Same, and Uses Thereof
An embodiment relates to a diamine compound, a polymer including a structural unit derived therefrom, a composition for forming a polyimide film including the polymer, and a polyimide film prepared by using the composition. Specifically, the diamine compound according to an embodiment may be very usefully used as a monomer for preparing a polyimide film that is colorless and has an improved mechanical strength.
Composition Containing Polyamideimide Precursor or Polyamideimide, and Polyamideimide Film Produced Using the Same
The present disclosure relates to a composition containing a polyamideimide precursor and/or polyamideimide, a polyamideimide film produced using the composition, and a display device including the polyamideimide film. The polyamideimide film produced using the composition and the display device including the polyamideimide film have excellent mechanical and optical properties.
DUAL HDAC6/PROTEASOME INHIBITORS, AND METHODS OF USE THEREOF
Dual HDAC6/proteasome inhibitors, and methods of using the same, are provided for treating disease.
DUAL HDAC6/PROTEASOME INHIBITORS, AND METHODS OF USE THEREOF
Dual HDAC6/proteasome inhibitors, and methods of using the same, are provided for treating disease.
NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS
The present disclosure compounds, as well as their compositions and methods of use. The compounds inhibit the activity of the TEAD transcription factor, and are useful in the treatment of diseases related to the activity of TEAD transcription factor including, e.g., cancer and other diseases.
NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS
The present disclosure compounds, as well as their compositions and methods of use. The compounds inhibit the activity of the TEAD transcription factor, and are useful in the treatment of diseases related to the activity of TEAD transcription factor including, e.g., cancer and other diseases.
Inhibitors of histone deacetylase
The present invention relates to compounds which inhibit histone deacetylase activity and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing these compounds. The present invention also relates to methods of treating and preventing hematological cell proliferative disorders, such as multiple myeloma, by administering these compounds and pharmaceutical compositions to subjects in need thereof.
Inhibitors of histone deacetylase
The present invention relates to compounds which inhibit histone deacetylase activity and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing these compounds. The present invention also relates to methods of treating and preventing hematological cell proliferative disorders, such as multiple myeloma, by administering these compounds and pharmaceutical compositions to subjects in need thereof.